Team:Arizona State/Data

From 2012.igem.org

(Difference between revisions)
Line 4: Line 4:
<body>
<body>
<h1>Data</h1>
<h1>Data</h1>
 +
<hr style="color: #800000; height:3px;" />
 +
<h2>Topoisomerase-based DNA Biosensor</h2>
<h2>Topoisomerase-based DNA Biosensor</h2>
 +
<hr style="color: #800000; height:3px;" />
<p>
<p>
-
<img src="https://static.igem.org/mediawiki/2012/8/8f/TopoDiagram.png" width="800" height="500">
+
<img src="https://static.igem.org/mediawiki/2012/8/8f/TopoDiagram.png" width="800" height="500" align="center" />
</p>
</p>
<h3>Data For Our New Favorite Parts</h3>
<h3>Data For Our New Favorite Parts</h3>
Line 27: Line 30:
This part should be paired with GFPT1. This part codes for a 20bp sequence that is complementary to a portion of the genomic GFP coding sequence that comes after the GFPT1 binding site in <i>E.coli</i> Keio strains.
This part should be paired with GFPT1. This part codes for a 20bp sequence that is complementary to a portion of the genomic GFP coding sequence that comes after the GFPT1 binding site in <i>E.coli</i> Keio strains.
</p>
</p>
 +
<br />
 +
<h2>Split Beta-Galactosidase Reporter System</h2>
<h2>Split Beta-Galactosidase Reporter System</h2>
 +
<hr style="color: #800000; height:3px;" />
<p>
<p>
Tested alpha fragment of beta-galactosidase for complementation with the omega fragment in vivo. A construct consisting of Streptavadin-Linker-Alpha fragment was transformed into BL21(DE3) <i>E.coli</i> cells that naturally express the omega fragment of beta-galactosidase. Quadrant streak plate in the presence of X-gal produced dark blue colonies. These results illustrate alpha-omega complementation <i>in vivo</i>. In vivo complementation indicates the ability of the two fragments to fuse into a functional beta-galactosidase unit, indicating that the split beta-galactosidase reporter system module of the biosensor was constructed and can be implemented successfully.
Tested alpha fragment of beta-galactosidase for complementation with the omega fragment in vivo. A construct consisting of Streptavadin-Linker-Alpha fragment was transformed into BL21(DE3) <i>E.coli</i> cells that naturally express the omega fragment of beta-galactosidase. Quadrant streak plate in the presence of X-gal produced dark blue colonies. These results illustrate alpha-omega complementation <i>in vivo</i>. In vivo complementation indicates the ability of the two fragments to fuse into a functional beta-galactosidase unit, indicating that the split beta-galactosidase reporter system module of the biosensor was constructed and can be implemented successfully.
Line 42: Line 48:
-
<div id='header' align="center">
+
<table align="center" width="950">
-
<table width="950">
+
<tr>
<tr>
<td>
<td>
Line 60: Line 65:
</td>
</td>
</table>
</table>
-
</div>
+
<br />
</p>
</p>
-
<h4>Current Research</h4>
+
<h2>Current Research</h2>
 +
<hr style="color: #800000; height:3px;" />
<p>
<p>
Current testing with the split beta-galactosidase system includes time-interval testing of colorimetric response, including quantitative measurements of beta-galactosidase concentration over time, omega fragment negative control testing, and in vitro testing of the alpha and omega fragments linked to streptavadin and Magainin.
Current testing with the split beta-galactosidase system includes time-interval testing of colorimetric response, including quantitative measurements of beta-galactosidase concentration over time, omega fragment negative control testing, and in vitro testing of the alpha and omega fragments linked to streptavadin and Magainin.

Revision as of 18:50, 21 October 2012

Data


Topoisomerase-based DNA Biosensor


Data For Our New Favorite Parts

D168A Double Cysteine Mutant of Smallpox Topoisomerase, BBa_K891234

This mutant version of topoisomerase recognizes the YCCTT motif in dsDNA. It cleaves after the last T in this motif, making a single stranded nick, and covalently binds to the 3' phosphate on that thymine.

GFPT1, BBa_K891000

This part should be paired with GFPT2. This part codes for a 20bp sequence that is complementary to a portion of the genomic GFP coding sequence in E.coli Keio strains.

GFPT2, BBa_K891999

This part should be paired with GFPT1. This part codes for a 20bp sequence that is complementary to a portion of the genomic GFP coding sequence that comes after the GFPT1 binding site in E.coli Keio strains.


Split Beta-Galactosidase Reporter System


Tested alpha fragment of beta-galactosidase for complementation with the omega fragment in vivo. A construct consisting of Streptavadin-Linker-Alpha fragment was transformed into BL21(DE3) E.coli cells that naturally express the omega fragment of beta-galactosidase. Quadrant streak plate in the presence of X-gal produced dark blue colonies. These results illustrate alpha-omega complementation in vivo. In vivo complementation indicates the ability of the two fragments to fuse into a functional beta-galactosidase unit, indicating that the split beta-galactosidase reporter system module of the biosensor was constructed and can be implemented successfully.

Notably, our data shows that the alpha fragment of beta-galactosidase was still able to complementarily bind to the omega fragment and produce a functional unit while linked to streptavidin, a toxic protein due to its high affinity towards biotin, an essential cofactor for fatty acid synthesis, valine synthesis, and gluconeogenesis. This indicates that the split beta-galactosidase reporter system can still be produced under harsh conditions and within a fusion protein construct. This parallels the conditions that we expect our probe to mature in, given that the beta-galactosidase fragments will also be fused to topoisomerase, which is also a toxic protein that binds DNA. This provides a proof-of-concept for the DNA-based biosensor, given that both modules of the final biosensor design work as expected.

After 6 Hours

After 12 Hours


Current Research


Current testing with the split beta-galactosidase system includes time-interval testing of colorimetric response, including quantitative measurements of beta-galactosidase concentration over time, omega fragment negative control testing, and in vitro testing of the alpha and omega fragments linked to streptavadin and Magainin.